Five clinicians and scientists at The Neuro have been awarded King Charles III Coronation Medals in recognition of their contributions to our understanding of neurological disease. The Coronation...
Since becoming only the second Alzheimer’s-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD...
The Canadian Institutes of Health Research's Project Grant: Spring 2025 competition has approved 435 research grants for a total investment of approximately $411M, with 123 projects funded in...
RSS